Lorlatinib and Bevacizumab Activity in ALK-Rearranged Lung Cancers After Lorlatinib Progression

被引：14

作者：

Choudhury, Noura J. ^{[1
]}

Young, Robert J. ^{[2
,3
]}

Sellitti, Matthew ^{[4
]}

Miller, Alexandra ^{[3
,4
]}

Drilon, Alexander ^{[1
,3
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA

[3] Weill Cornell Med Coll, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Sloan Kettering Adv Imaging Lab, 1275 York Ave, New York, NY 10021 USA

来源：

JCO PRECISION ONCOLOGY | 2020年 / 4卷

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1200/PO.20.00271

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1333 / 1338

页数：6

共 25 条

[1] Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer [J].

Bauer, Todd M. ;

Shaw, Alice T. ;

Johnson, Melissa L. ;

Navarro, Alejandro ;

Gainor, Justin F. ;

Thurm, Holger ;

Pithavala, Yazdi K. ;

Abbattista, Antonello ;

Peltz, Gerson ;

Felip, Enriqueta .

TARGETED ONCOLOGY, 2020, 15 (01) :55-65

[2] Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity [J].

Dagogo-Jack, Ibiayi ;

Rooney, Marguerite ;

Lin, Jessica J. ;

Nagy, Rebecca J. ;

Yeap, Beow Y. ;

Hubbeling, Harper ;

Chin, Emily ;

Ackil, Jennifer ;

Farago, Anna F. ;

Hata, Aaron N. ;

Lennerz, Jochen K. ;

Gainor, Justin F. ;

Lanman, Richard B. ;

Shaw, Alice T. .

CLINICAL CANCER RESEARCH, 2019, 25 (22) :6662-6670

[3]

Ellis LM, 2006, SEMIN ONCOL, V33, pS1, DOI 10.1053/j.seminoncol.2006.08.002

[4] Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer [J].

Gainor, Justin F. ;

Dardaei, Leila ;

Yoda, Satoshi ;

Friboulet, Luc ;

Leshchiner, Ignaty ;

Katayama, Ryohei ;

Dagogo-Jack, Ibiayi ;

Gadgeel, Shirish ;

Schultz, Katherine ;

Singh, Manrose ;

Chin, Emily ;

Parks, Melissa ;

Lee, Dana ;

DiCecca, Richard H. ;

Lockerman, Elizabeth ;

Huynh, Tiffany ;

Logan, Jennifer ;

Ritterhouse, Lauren L. ;

Le, Long P. ;

Muniappan, Ashok ;

Digumarthy, Subba ;

Channick, Colleen ;

Keyes, Colleen ;

Getz, Gad ;

Dias-Santagata, Dora ;

Heist, Rebecca S. ;

Lennerz, Jochen ;

Sequist, Lecia V. ;

Benes, Cyril H. ;

Iafrate, A. John ;

Mino-Kenudson, Mari ;

Engelman, Jeffrey A. ;

Shaw, Alice T. .

CANCER DISCOVERY, 2016, 6 (10) :1118-1133

[5]

Iwamoto FM, 2010, ARCH NEUROL-CHICAGO, V67, P285, DOI 10.1001/archneurol.2010.11

[6] Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers [J].

Jain, Rakesh K. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (17) :2205-U210

[7] Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis [J].

Johung, Kimberly L. ;

Yeh, Norman ;

Desai, Neil B. ;

Williams, Terence M. ;

Lautenschlaeger, Tim ;

Arvold, Nils D. ;

Ning, Matthew S. ;

Attia, Albert ;

Lovly, Christine M. ;

Goldberg, Sarah ;

Beal, Kathryn ;

Yu, James B. ;

Kavanagh, Brian D. ;

Chiang, Veronica L. ;

Camidge, D. Ross ;

Contessa, Joseph N. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02) :123-+

[8] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF BEVACIZUMAB THERAPY FOR RADIATION NECROSIS OF THE CENTRAL NERVOUS SYSTEM [J].

Levin, Victor A. ;

Bidaut, Luc ;

Hou, Ping ;

Kumar, Ashok J. ;

Wefel, Jeffrey S. ;

Bekele, B. Nebiyou ;

Prabhu, Sujit ;

Loghin, Monica ;

Gilbert, Mark R. ;

Jackson, Edward F. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05) :1487-1495

[9] Response assessment criteria for brain metastases: proposal from the RANO group [J].

Lin, Nancy U. ;

Lee, Eudocia Q. ;

Aoyama, Hidefumi ;

Barani, Igor J. ;

Barboriak, Daniel P. ;

Baumert, Brigitta G. ;

Bendszus, Martin ;

Brown, Paul D. ;

Camidge, D. Ross ;

Chang, Susan M. ;

Dancey, Janet ;

de Vries, Elisabeth G. E. ;

Gaspar, Laurie E. ;

Harris, Gordon J. ;

Hodi, F. Stephen ;

Kalkanis, Steven N. ;

Linskey, Mark E. ;

Macdonald, David R. ;

Margolin, Kim ;

Mehta, Minesh P. ;

Schiff, David ;

Soffietti, Riccardo ;

Suh, John H. ;

van den Bent, Martin J. ;

Vogelbaum, Michael A. ;

Wen, Patrick Y. .

LANCET ONCOLOGY, 2015, 16 (06) :E270-E278

[10] Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Nakagawa, Kazuhiko ;

Garon, Edward B. ;

Seto, Takashi ;

Nishio, Makoto ;

Aix, Santiago Ponce ;

Paz-Ares, Luis ;

Chiu, Chao-Hua ;

Park, Keunchil ;

Novello, Silvia ;

Nadal, Ernest ;

Imamura, Fumio ;

Yoh, Kiyotaka ;

Shih, Jin-Yuan ;

Au, Kwok Hung ;

Moro-Sibilot, Denis ;

Enatsu, Sotaro ;

Zimmermann, Annamaria ;

Frimodt-Moller, Bente ;

Visseren-Grul, Carla ;

Reck, Martin .

LANCET ONCOLOGY, 2019, 20 (12) :1655-1669

← 1 2 3 →